Wellmedr vs Enhance MD: Pricing, Compounds, and Terms
Comparing Wellmedr vs Enhance MD quickly: Wellmedr emphasizes lifetime locked-in pricing and same-day review while Enhance MD highlights the lowest first-month semaglutide price and flat-rate dosing. Early verdict: pick Wellmedr if lifetime locked pricing and same-day review with free overnight shipping matter most; pick Enhance MD if the lowest first-month cost and flat-rate, no escalation pricing matter more.
Explore Wellmedr plans starting at $89/mo
How these providers differ at a glance
This comparison focuses on five supported differences between Wellmedr and Enhance MD: starting price structure, pricing guarantees and escalation, compound availability, clinical process and extras, and regulatory/packaging notes. All statements below reflect the captured landing-page evidence and presented qualifiers.
1. Pricing and introductory rates
Wellmedr lists GLP-1 plans starting at $89/month and semaglutide starting at $49 a month in some plans, with promotional offers described on landing pages. Enhance MD advertises semaglutide from $49 for the first month and tirzepatide from $99 for the first month. The clear supported difference: Enhance MD highlights the lowest first-month semaglutide price of $49 explicitly as an introductory rate.
What that means for new patients
Enhance MD positions itself for cost-sensitive beginners by publishing the $49 first-month price. Wellmedr advertises plans starting at $89/month and separate semaglutide monthly plan starting at $49 in some offers, but the captured evidence emphasizes Wellmedr’s plan-level starting points and promotional bundles.
See Enhance MD first-month semaglutide offers
2. Pricing guarantees and escalation
Wellmedr promotes “lifetime locked-in pricing” and “no dose-based price increases” as defining features. Enhance MD emphasizes “flat-rate pricing: the same price at every dose, with no fee escalation during titration” and notes that the $49/$99 rates are first-month introductory prices while ongoing flat rates are higher. The supported distinction is that Wellmedr markets a lifetime-locked promise, while Enhance MD highlights flat-rate ongoing dosing after introductory pricing.
3. Compound availability and options
Both providers offer semaglutide and tirzepatide in some form. Enhance MD explicitly markets both semaglutide and tirzepatide on one platform and notes tirzepatide from $99 the first month. Wellmedr lists semaglutide and tirzepatide options including Ozempic and Zepbound pricing references on landing pages, and specifically states it offers compounded GLP-1 medications from licensed U.S. pharmacies. The difference supported by the sources is Enhance MD’s marketing focus on multi-compound availability with competitive introductory pricing, while Wellmedr highlights plan types and multiple named products alongside compounded offerings.
4. Clinical process, shipping, and extras
Wellmedr advertises same-day review plus free overnight shipping, on-time refills guaranteed, and claims like “cancel or change anytime” on monthly plans. Enhance MD mentions clinician-directed review, metabolic lab testing every six months in some published pricing examples, and a clinician-directed platform that has treated 10,000+ patients per captured landing-page evidence. Wellmedr emphasizes immediate service-level promises; Enhance MD emphasizes ongoing clinical monitoring and patient volume in its captured copy.
Check Wellmedr shipping and plan details
5. Regulatory and compound status
Both sources include the regulatory qualifier that their compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness or quality. Wellmedr explicitly states: “Compounded medications are regulated by state Boards of Pharmacy, but are not evaluated by the FDA for safety or efficacy.” Enhance MD likewise notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. This shared regulatory note is important for comparisons about compounded GLP-1s.
Comparison table: Wellmedr vs Enhance MD
| Criteria | Wellmedr | Enhance MD |
|---|---|---|
| Starting price (semaglutide) | Semaglutide listed starting at $49/month in plan copy; GLP-1 plans from $89/mo | Semaglutide from $49 for the first month |
| Pricing guarantee | Lifetime locked-in pricing; no dose-based price increases claimed | Flat-rate pricing; $49/$99 are first-month intro prices, ongoing flat rate applies |
| Compound options | Semaglutide and tirzepatide offered, mentions Ozempic and Zepbound in copy | Both semaglutide and tirzepatide on one platform; highlights both introductory prices |
| Clinical extras | Same-day review, free overnight shipping, on-time refills guaranteed | Metabolic lab testing every 6 months, clinician-directed care, 10,000+ patients treated |
| Regulatory note | Compounded meds not evaluated by FDA; regulated by state Boards of Pharmacy | Compounded meds are not FDA-approved finished products and are not reviewed by FDA |
Key takeaways and final notes
Wellmedr vs Enhance MD comes down to whether you prioritize a lifetime locked-in pricing promise and same-day shipping or the absolute lowest published first-month semaglutide price and explicit flat-rate dose pricing. Both platforms present compounded GLP-1 options and include regulatory qualifiers that compounded medications are not FDA-approved finished products and are not reviewed by the FDA.
Compare Enhance MD flat-rate plans
Choose Wellmedr if you value lifetime locked-in pricing, no dose-based price increases as advertised, and same-day review with free overnight shipping. Choose Enhance MD if you want the lowest supported first-month semaglutide price ($49 first month), flat-rate pricing that avoids dose escalation, and access to both semaglutide and tirzepatide on one platform. All treatment availability and pricing are subject to clinician review and the specific terms shown on each provider’s landing pages.